Daniel Gröner
Has participated in:
-
Characterization of dexamethasone-induced gemcitabine resistance, cancer stem cell properties and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma
-
Norepinephrine transporter–targeted cancer theranostics — new horizons
-
Hämatologische Sicherheit der 177Lu-PSMA-617 Radioligandentherapie bei Patienten mit metastasiertem kastrationsresistentem Prostatakarzinom
-
A multicenter survey of current practices of 99mTc-methoxy-isobutyl-isonitrile (MIBI) imaging for the diagnosis of thyroid nodules: more standardization is essential